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Soluble Epoxide Hydrolase (sEH) is an enzyme which has a C-terminal epoxide 
hydrolase and N-terminal phosphatase activities. The endogenous substrates for 
epoxide hydrolase (EH) activity are epoxyeicosatrienoic acids (EETs), which have 
biological functions such as vasodilation, anti-inflammation, and angiogenesis. In 
previous study in our laboratory, it was found that the substrates for phosphatase 
domain are lysophosphatidic acids (LPAs), which have biological roles in cell 
proliferation and motility. It was also found that overexpression of phosphatase activity 
of sEH suppressed VEGF expression and cell growth. In human, sEH has six genetic 
variants of polymorphism (K55R, R103C, C154Y, R287Q, V422A, and E470G). It is 
reported that K55R increases the risk of ischemic stroke, and R287Q enhances insulin 
resistance in type II diabetes patients. However, the activities of these variants toward 
endogenous substrates including EETs and LPAs are not well known. In this study, the 
effects of sEH polymorphism on EH and phosphatase activities toward synthetic 
substrates, PHOME and 4-methylumbelliferyl phosphate (4-MUP) were investigated. 
We also investigated EH activity toward EETs and phosphatase activity toward 
LPAs.EH activities of all variants toward PHOME were almost same compared with 
wild type (WT) sEH. Phosphatase activities toward 4-MUP of all variants except E470G 
were lower than WT, but some variants had higher phosphatase activity toward LPAs 
than WT did. These results suggest that the effects of substitution of amino acid in sEH 
polymorphism on phosphatase activities toward endogenous and synthetic substrates 
are different. The changes in phosphatase activity of sEH polymorphism may affect the 
physiological functions of LPAs. 
